LEVEMIR FLEXPEN contains insulin detemir — a long-acting recombinant human insulin analogue designed for prolonged and steady release after subcutaneous injection, mimicking basal insulin secretion.
Recommended for:
Type 1 and type 2 diabetes requiring basal insulin support for glycaemic control.
Administered subcutaneously into the thigh, abdomen, or upper arm once or twice daily. Dosage is individualized by the physician based on glucose monitoring, body weight, and diet.
Contraindications:
Side effects: